Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Halbmayer

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Prediction of recurrent venous thromboembolism by the activated partial thromboplastin timeG Hron, S Eichinger, A Weltermann, et al.
Thrombosis and Haemostasis|January 1, 1994
The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donorsW M Halbmayer, A Haushofer, R Schön, et al.
Zeitschrift Fur Kardiologie|January 1, 1995
[Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent]M Dittel, A Haushofer, R Spiel, et al.
Thrombosis and Haemostasis|February 12, 1991
C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsiaW M Halbmayer, P Hopmeier, C Mannhalter, et al.
Wiener Klinische Wochenschrift|July 13, 1990
[A simple test for the monitoring of plasma anti-XA activity of patients following subcutaneous administration of enoxaparin]W M Halbmayer, C Feichtinger, T Schwarz, et al.
Deutsche Medizinische Wochenschrift (1946)|October 29, 1993
[Recurrent venous thromboses in hypoplasia of the vena cava inferior and factor XII deficiency]W M Halbmayer, J Radek, P Duschet, et al.
The Clinical Investigator|July 1, 1994
High-dose intravenous melphalan in a patient with multiple myeloma and oliguric renal failureM Pecherstorfer, I Zimmer-Roth, S Weidinger, et al.
British Journal of Haematology|December 31, 1997
A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiencyS Mustafa, I Pabinger, K Vàradi, et al.
Blood|November 14, 1997
Mutations in the human factor XII geneM Schloesser, S Zeerleder, G Lutze, et al.
Wiener Klinische Wochenschrift|May 12, 2012
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional managementA Weltermann, M Brodmann, H Domanovits, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Prediction of recurrent venous thromboembolism by the activated partial thromboplastin timeG Hron, S Eichinger, A Weltermann, et al.
Thrombosis and Haemostasis|January 1, 1994
The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donorsW M Halbmayer, A Haushofer, R Schön, et al.
Zeitschrift Fur Kardiologie|January 1, 1995
[Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent]M Dittel, A Haushofer, R Spiel, et al.
Thrombosis and Haemostasis|February 12, 1991
C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsiaW M Halbmayer, P Hopmeier, C Mannhalter, et al.
Wiener Klinische Wochenschrift|July 13, 1990
[A simple test for the monitoring of plasma anti-XA activity of patients following subcutaneous administration of enoxaparin]W M Halbmayer, C Feichtinger, T Schwarz, et al.
Deutsche Medizinische Wochenschrift (1946)|October 29, 1993
[Recurrent venous thromboses in hypoplasia of the vena cava inferior and factor XII deficiency]W M Halbmayer, J Radek, P Duschet, et al.
The Clinical Investigator|July 1, 1994
High-dose intravenous melphalan in a patient with multiple myeloma and oliguric renal failureM Pecherstorfer, I Zimmer-Roth, S Weidinger, et al.
British Journal of Haematology|December 31, 1997
A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiencyS Mustafa, I Pabinger, K Vàradi, et al.
Blood|November 14, 1997
Mutations in the human factor XII geneM Schloesser, S Zeerleder, G Lutze, et al.
Wiener Klinische Wochenschrift|May 12, 2012
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional managementA Weltermann, M Brodmann, H Domanovits, et al.
Pageof 4